Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Int J Antimicrob Agents. 2023 Jan 20;61(3):106736. doi: 10.1016/j.ijantimicag.2023.106736

Table 3:

Clinical Outcome of Patients with Streptococcal Infection, Stratified by Treatment with IV Only versus PO Stepdown Antibiotics.

Variable1 Overall
(n=244)
IV only
(n=153)
PO stepdown
(n=111)
P value
Primary outcome
Clinical failure 2 57 (21.6) 37 (24.2) 20 (18.0) 0.233
90-day mortality 7/262 (2.7) 4/152 (2.6) 3/110 (2.7) 1.003
Readmission within 90 days 53 (20.1) 35 (22.9) 18 (16.2) 0.183
Readmission due to recurrent strep bacteremia 6/53 (11.3) 5/35 (14.3) 1/18 (5.6) 0.653
Secondary outcomes
Length of stay (days) 5 (4-9) 7 (5-13.5) 4 (3-5) < 0.0014
Discharge home 192 (72.7) 98 (64.1) 94 (84.7) 0.0013,5
Antibiotic-associated adverse events 6 4 (1.5) 2 (1.3) 2 (1.8) 0.743

Abbreviations: IV, intravenous; N, number of patients; PO, per os

1

Data presented as n (%) or as median (interquartile range).

2

Composite of 90-day mortality and/or 90-day readmission

3

Chi square test with continuity correction,

4

Mann Whitney U test

5

Comparison used between home versus skilled nursing plus rehabilitation facility, plus self-directed discharge,

6

Types of antibiotic associated with adverse events included Clostridium difficile infection (n=2), leukopenia (n=1), and skin rash (n=1).